Stock Watch: Merck And Pfizer Reclaim Pharmaceutical Defensiveness
Different Post-Pandemic Narratives, But Similar Full-Year Guidance Increases
Merck grew sales, increased financial guidance and beat analysts’ expectations, noting a base business recovery from the pandemic. Pfizer increased guidance and beat expectations for different reasons.
